Abstract
Post-COVID-19 syndrome (PCS) summarizes persisting sequelae after infection with the severe-acute-respiratory-syndrome-Coronavirus-2 (SARS-CoV-2). PCS can affect patients of all covid-19 disease severities. As previous studies revealed impaired blood flow as a provoking factor for triggering PCS, it was the aim of the present study to investigate a potential association of self-reported chronic fatigue and retinal microcirculation in patients with PCS, potentially indicating an objective biomarker.
A prospective study was performed, including 201 subjects: 173 patients with PCS and 28 controls. Retinal microcirculation was visualized by OCT-Angiography (OCT-A) and quantified by the Erlangen-Angio-Tool as macula and peripapillary vessel density (VD). Chronic Fatigue (CF) was assessed with the variables ‘Bell score’, age and gender. The VD in the superficial vascular plexus (SVP), intermediate capillary plexus (ICP) and deep capillary plexus (DCP) were analyzed considering the repetitions (12 times). Taking in account of such repetitions a mixed model was performed to detect possible differences in the least square means between different groups of analysis.
An age effect on VD was observed between patients and controls (p<0.0001). Gender analysis yielded that women with PCS showed lower VD levels in SVP compared to male patients (p=0.0015). The PCS patients showed significantly lower VD of ICP as compared to the controls (p=0.0001, [CI: 0.32; 1]). Moreover, considering PCS patients, the mixed model reveals a significant difference between chronic fatigue (CF) and without CF in VD of SVP (p=0.0033, [CI: -4.5; -0.92]). The model included age, gender and the variable ‘Bell score’, representing a subjective marker for CF. Consequently, the retinal microcirculation might be an objective biomarker in subjective-reported chronic fatigue of patients with PCS.
Competing Interest Statement
The authors declare no conflict of interest in the present topic of the study. Hohberger B (Heidelberg Engineering), Harrer T (none), Kruse F (none), Hoffmanns J (none), Rogge L (none), Heltmann F (none), Moritz M (none), Beitlich L (none), Lucio M (none), Schlick S (none), Schottenhamml J (none), Laemmer R (none), Herrmann M (none), Mardin C (Heidelberg Engineering), Skornia A (none), Bartsch A (none).
Funding Statement
The present study was funded by Bavarian Health and Food Safety Authority (LGL; 2490-PC-2021-V14): Discover – Establishment and evaluation of a clinical algorithms for an objective diagnosis of subtypes of Long–COVID as essential basis for an effective patients care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The studies involving human participants were reviewed and approved by the ethics committee of the University of Erlangen-Nuernberg (295_20 B). The patients/participants provided their written informed consent to participate in this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
sarah.schlick{at}t-online.de (S.S.); charlotte.sz{at}yahoo.com (C.S.); christian.mardin{at}uk-erlangen.de (C.M.); j.j.hoffmanns{at}web.de (J.H.); thorakathari-na.schroeder{at}extern.uk-erlangen.de (T.S.); franziraith{at}gmx.de (F.R.); roggelennart{at}aol.com (L.R.); felix-heltmann{at}web.de (F.H.); michael.felix.moritz{at}hotmail.de (M.M.); lorenzbeitlich{at}gmail.com (L.B.); julia.schottenhamml{at}uk-erlangen.de (J.S.); friedrich.kruse{at}uk-erlangen.de (F.K.); robert.laemmer{at}uk-erlangen.de (R.L.); adam.skornia{at}uk-erlangen.de (A.S.); alexander.bartsch{at}uk-erlangen.de (A.B.)
marianna.lucio{at}helmholtz-muenchen.de
martin.herrmann{at}uk-erlangen.de (M.H.); thomas.harrer{at}uk-erlangen.de (T.H.)
marion.ganslmayer{at}uk-erlangen.de
↵† Shared first authorship.
↵†† Shared last authorship.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
